AFI Capital Partners
VC Fund
Seattle, United States
AFI Capital Partners is a growth equity fund
- Total investments:
- 11
- Last investment:
- Lead investor:
- 45%
- Fund size:
- $3.5M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries AFI Capital Partners invests in
Stages AFI Capital Partners invests in
Countries AFI Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3.5M–$6M
- Series A
- $12M–$20M
- Series B
- $8.5M–$21M
Investment Focus
Industry
- Cannabis 7 (64%)
- Biotechnology 3 (27%)
- Alternative Medicine 2 (18%)
- SaaS 1 (9%)
- Retail 1 (9%)
Stage
- Series A 4 (36%)
- Series B 3 (27%)
- Seed 2 (18%)
- Venture - Series Unknown 1 (9%)
Country
- United States 8 (73%)
- Mexico 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Nico Richardson
Co-Founder and Managing Director
|
Co-Founder and Managing Director | Total investments: 1 | Find email | |
|
Chi-Chien Hou
Co-Founder & Managing Director
|
Co-Founder & Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Botanica Seattle specializes in the production of natural and handmade cannabis edibles. Its products include mixed fruit chews, chocolate pattie, infused cannabis oil, and cannabis mint made from an alcohol-based extraction process with multiple stages of quality control to guarantee accurate and consistent dosing during final formulation,enabling people to enjoy the taste of handmade cannabis product.The company was founded in 2013 and is headquartered in Seattle, Washington. | $9M / Series B / Jul 13, 2023 | ||
| Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics. The company focuses on the production of cannabis for researchers across the United States and the USDA-compliant THC testing of hemp. | $20M / Series A / Oct 04, 2022 | ||
| Compassionate Cultivation is a medical cannabis company that grows, processes, and dispenses CBD medicine.The company provides patient consultations, physician outreach resources, and detailed information on their products and retail merchandise. Conditions including epilepsy, seizure disorders, multiple sclerosis, spasticity, ALS, autism,terminal cancer, CTE, and other incurable neurodegenerative disorder now have access to medically prescribed cannabis. | $21M / Series B / Jun 07, 2021 | ||
| SweetFlower is Southern California's largest and leading independent cannabis retailer. They believe in creating a cannabis culture that is approachable and sophisticated and treats cannabis as a consumer packaged good. Their stores provide concierge-level service —approachable, knowledgeable, and equipped to help everyone from the cannabiscurious to the flower fluent. | $15M / Series A / Mar 29, 2021 | ||
| Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $18.7M / Series B / Feb 14, 2020 | ||
| Vertosa creates industry-leading active ingredients for infused product makers. Our patent pending nano- and micro-emulsions are carefully designed for the specific needs of each of our customers. Our pre-suspended aqueous solutions empower you to create incredibly homogenous and stable products while maximizing bioavailability, clarity, and taste.We work closely with you and our lab partners throughout the manufacturing process to achieve target potency and accelerate your products to market. | $6M / Seed / Dec 04, 2019 | ||
| Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $8.5M / Series B / Sep 16, 2019 | ||
| Willow Industries provides cutting edge technology for post-harvest microbial decontamination in cannabis. Based in Denver, CO, they provide state-of-the-art technology to clean and purify flower & trim. Their patent-pending machine, WillowPure, uses ozone-based oxidation to reduce mold, yeast, mildew, Aspergillus, Salmonella, E. Coli andother potential pathogens. All while protecting the medicinal properties, aroma, potency and visual appearance of the flower. | $2M / Venture - Series Unknown / Jun 12, 2019 | ||
| Headset is a data-driven tech company that provides a business intelligence platform for the cannabis industry. Their services cover an array of specialized needs that businesses in the industry have, be they growers, extractors, processors, or retailers. The company's mission is to help operators make more informed business decisions throughdata. It aggregates multiple reporting sources to help analysts, producers, and retailers see opportunities and stay ahead of product trends.The company was founded in 2015 and is based in Seattle, Washington. | $12.1M / Series A / Jan 08, 2019 | ||
| Treez is an enterprise cloud commerce platform that streamlines retail and supply chain operations within the cannabis market. Through its innovative technology for retailers and brands, the company provides a robust breadth and depth of software solutions required to operate a successful modern dispensary.Solutions include point of sale,dispensary inventory management, and omnichannel sales capabilities all on a mission-critical platform that ensures regulatory compliance across every supply chain transaction. The innovative platform also connects essential brands with their retailers through a centralized brand catalog with real-time market insights. The extensible open API platform provides smooth integration into a variety of best-of-breed solutions, including CRM, marketplace, and data analytics across the partner ecosystem, giving retailers everything they need to grow their business. | $11.5M / Series A / Sep 10, 2018 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does AFI Capital Partners invest in?
AFI Capital Partners invests primarily in Cannabis, Biotechnology and Alternative Medicine startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is AFI Capital Partners's check size?
AFI Capital Partners typically joins rounds of $3.5M–$6M at Seed, $12M–$20M at Series A and $8.5M–$21M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds AFI Capital Partners participates in.
How do I contact AFI Capital Partners?
Public channels for AFI Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at AFI Capital Partners?
The team at AFI Capital Partners includes Nico Richardson (Co-Founder and Managing Director) and Chi-Chien Hou (Co-Founder & Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
